Sublingual Immunotherapy for Canine Atopic Dermatitis: A Guide for Veterinarians

Canine atopic dermatitis is a common diagnosis, affecting as much as 3-10% of the canine population. Allergen-specific immunotherapy (ASIT) via subcutaneous injection – “allergy shots” – has efficacy in as many as 70% of treated patients; however, it requires weekly to twice-monthly injections. Owners who find injections difficult to administer, or who are frightened of needles, can turn to sublingual immunotherapy (SLIT).


Sublingual Immunotherapy for Canine Atopic Dermatitis: A Guide for Veterinarians - cover page
Category
Health Care
Document type
Other
Language
English
Pages
6
File format
PDF
File size
1.2 MB
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
4A4A2926D10199DD863A74658E468A87

About this manual

Sublingual immunotherapy for pets is presented as a guide for veterinarians. The text describes canine atopic dermatitis as a common diagnosis and notes that allergen-specific immunotherapy by subcutaneous injection has efficacy in as many as 70% of treated patients but requires frequent injections. It introduces sublingual immunotherapy, or “allergy drops,” as a form of allergen-specific immunotherapy and compares its glycerin-stabilized formulation with the phenol-saline extracts used for injection.

The document reviews the sublingual route in humans, including antigen uptake by dendritic cells, regulatory T-cells, and cytokines such as IL-10. It also reviews efficacy evidence, citing double-blind, placebo-controlled SLIT studies and a Cochrane review that found SLIT reduced symptoms by 42 percent and medication need by 43 percent.

What's inside

  • Canine atopic dermatitis
  • Allergen-specific immunotherapy
  • Sublingual immunotherapy in humans
  • Review of Mechanism
  • Review of Evidence for Efficacy

Frequently asked questions

What is sublingual immunotherapy (SLIT)?

It is a form of allergen-specific immunotherapy, often called “allergy drops,” in which specific antigens placed under the tongue induce immunologic tolerance.

How much did SLIT reduce symptoms and medication need in the Cochrane review?

Across all trials, SLIT reduced symptoms by 42 percent and reduced medication need by 43 percent.

How long has allergen-specific immunotherapy been used in animals?

ASIT has been used in dogs, cats and horses for over 40 years.

Does SLIT use the same formulation as injection immunotherapy?

No. Allergy shots use phenol-saline based allergen extracts, while SLIT is formulated with glycerin-stabilized extracts in a vehicle that augments uptake through the oral mucosa.

Download PDF (1.2 MB)

Also Manuals